Ovarian cysts are most commonly diagnosed with a transvaginal ultrasound, which can identify the type, size, and internal structure of a cyst with high accuracy. But the path to that ultrasound often starts with a physical exam or an incidental finding on imaging done for another reason. Here’s what the full diagnostic process looks like and what each step tells your doctor.
What a Pelvic Exam Can and Can’t Tell You
A pelvic exam is often the first step, but it has real limitations. During a bimanual exam, your doctor places one hand on your lower abdomen and two fingers inside the vagina to feel for enlargement or tenderness near your ovaries. If a cyst is large enough, it may be felt as a mass.
The problem is that pelvic exams miss most ovarian cysts. In controlled studies, the sensitivity for detecting a mass near the ovary ranged from just 15% to 36%, meaning the majority of actual cysts went undetected by touch alone. Factors like body weight, uterine size, and abdominal scarring make palpation even less reliable. Examiners also tended to underestimate the size of masses they did find. Neither the National Cancer Institute nor the U.S. Department of Health and Human Services endorses pelvic exams as a screening tool for ovarian disease because of these accuracy gaps.
So a pelvic exam can raise suspicion, but it cannot confirm or rule out an ovarian cyst on its own. When something feels off, or when you’re having symptoms like pelvic pain or bloating, imaging is the next step.
Ultrasound: The Primary Diagnostic Tool
Transvaginal ultrasound is the gold standard for evaluating ovarian cysts. A small probe is inserted into the vagina, which places it close to the ovaries and produces detailed images. The exam is quick, doesn’t involve radiation, and gives your doctor a clear picture of the cyst’s size, shape, internal contents, and blood flow.
What makes ultrasound so useful is that different types of cysts have distinct visual signatures. A simple functional cyst, the most common kind, appears as a fluid-filled pocket with thin, smooth walls, no internal solid areas, and no blood flow within it. These are almost always harmless and often resolve on their own.
A hemorrhagic cyst, one that has bled internally, may look partially solid on the screen but gives itself away by showing no blood flow in the solid-looking area. The clot inside typically has concave (inward-curving) edges, which helps distinguish it from a true solid growth.
An endometrioma, sometimes called a “chocolate cyst” because of the old blood it contains, has a characteristic ground-glass appearance on ultrasound. It looks uniformly hazy inside, with no blood flow detected and sometimes small bright spots along the cyst wall. About 30% of endometriomas show these bright wall spots.
A dermoid cyst (mature teratoma) is one of the most distinctive. These cysts can contain fat, hair, and even calcified tissue like teeth. On ultrasound, they often show a bright nodule inside, may have visible lines from floating hair, and sometimes display a fat-fluid level where lighter fatty material sits on top of denser fluid. Around 90% are single-chambered, and roughly 30% contain calcifications.
How Doctors Score What They See
Radiologists don’t just describe what they see on ultrasound. They now use a standardized scoring system called O-RADS (Ovarian-Adnexal Reporting and Data System) to categorize findings by their risk of being cancerous. This system gives your doctor a consistent, evidence-based framework for deciding what happens next.
- O-RADS 1: Normal ovary, no cyst. Zero risk of malignancy.
- O-RADS 2: Almost certainly benign. Less than 1% risk. This includes most simple cysts and classic hemorrhagic cysts.
- O-RADS 3: Low risk, between 1% and 10%. These may need follow-up imaging.
- O-RADS 4: Intermediate risk, between 10% and 50%. These typically prompt further evaluation or referral.
- O-RADS 5: High risk, 50% or greater chance of malignancy. These usually lead to surgical consultation.
Your ultrasound report will include one of these categories, which directly shapes whether your doctor recommends watchful waiting, additional imaging, or a referral to a specialist.
When MRI or CT Scans Are Needed
Ultrasound answers the question most of the time, but some cysts don’t fit neatly into a clear category. When ultrasound results are indeterminate, MRI is the most useful next step. It increases the specificity of the evaluation, meaning it’s better at confirming whether a cyst is benign, which helps avoid unnecessary surgery. Women who are clinically at low risk for cancer but have an unclear ultrasound finding benefit most from MRI.
MRI is particularly helpful in two situations: when a cyst appears mostly solid and needs more detailed tissue characterization, and when a complex cystic mass needs to be confirmed as an endometrioma. MRI can also pick up rare signs of cancerous changes within an endometrioma that ultrasound would miss.
CT scans play a different role. They aren’t typically used to figure out what kind of cyst you have. Instead, CT is reserved for cases where ovarian cancer has already been identified or is strongly suspected, and the goal is to map how far the disease has spread before planning treatment.
Blood Tests and the CA-125 Marker
A blood test measuring a protein called CA-125 is sometimes ordered alongside imaging, but it’s not a standalone diagnostic tool. Its most common use is actually for monitoring ovarian cancer treatment or checking for recurrence, not for initial cyst diagnosis.
When CA-125 is used during cyst evaluation, it’s typically because imaging has already revealed a suspicious or complex mass. Elevated levels can raise concern for cancer, but many benign conditions also push CA-125 higher: endometriosis, pelvic inflammatory disease, uterine fibroids, liver disease, and even normal menstruation or pregnancy. Because of these false positives, an elevated CA-125 alone doesn’t mean cancer, and a normal level doesn’t guarantee a cyst is harmless.
For women at very high risk of ovarian cancer due to genetic factors or strong family history, CA-125 may be used as a screening tool in combination with ultrasound.
Why Ovarian Cysts Are Not Biopsied
Unlike lumps in the breast or thyroid, ovarian cysts are almost never biopsied with a needle before surgery. The concern is that puncturing a cyst that turns out to be cancerous could rupture it and spill malignant cells into the abdominal cavity, potentially spreading the disease. This risk of “seeding” means doctors rely on imaging, blood markers, and scoring systems to assess a cyst’s nature before deciding on surgery. If a cyst needs to be removed, the tissue is examined by a pathologist after it comes out, not before.
Follow-Up Imaging Timelines
Not every cyst needs immediate treatment or even close monitoring. In postmenopausal women, guidelines from the Royal College of Obstetricians and Gynaecologists provide clear size-based thresholds. Simple, single-chambered cysts that are 3 centimeters or smaller don’t require routine follow-up at all. Cysts between 3 and 5 centimeters with normal CA-125 levels can be monitored conservatively, with a repeat ultrasound in four to six months. If the cyst stays the same size or shrinks over a year, and CA-125 remains normal, it’s generally reasonable to stop monitoring.
In premenopausal women, the approach is even more conservative because functional cysts are extremely common and most resolve within one to three menstrual cycles. Your doctor may simply recommend a repeat ultrasound after six to eight weeks to confirm the cyst has gone away on its own. Persistent or growing cysts, or those with complex features on ultrasound, get a closer look with the tools described above.